OPA-15406

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OPA-15406, covering 2016-10-03 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis [Phase 3]